Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
121,543,157
-
Total 13F shares
-
13,964,620
-
Share change
-
-214,297
-
Total reported value
-
$45,943,000
-
Price per share
-
$3.29
-
Number of holders
-
17
-
Value change
-
-$779,902
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q1 2020
As of 31 Mar 2020,
Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,964,620 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., NEA Management Company, LLC, Omega Fund Management, LLC, FMR LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, BANCO BILBAO VIZCAYA ARGENTARIA, S.A., and Schonfeld Strategic Advisors LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.